Cardlytics, Inc. Form 8-K Summary
Business Context and Reporting Period
Cardlytics, Inc. (CDLX) filed this Current Report on Form 8-K on January 23, 2026. The filing discloses the entry into a Material Definitive Agreement regarding the sale of specific company assets.
Key Financial Metrics and Transaction Terms
This filing does not report standard periodic financial metrics such as revenue, profit, cash flow, or debt levels. Instead, it details the financial terms of an asset purchase agreement:
- Transaction Type: Asset Purchase Agreement for the "Bridg" platform assets.
- Buyer: DB Sub, LLC, an indirectly wholly owned subsidiary of PAR Technology Corporation ("PAR").
- Consideration: PAR Common Stock valued at a base of $27,500,000, subject to adjustments for new customer contracts and revenue timing.
- Consideration Cap: The total value of the stock consideration shall not exceed $30,000,000.
- Valuation Method: The number of shares is calculated by dividing the adjusted consideration amount by the 15-day volume-weighted average price of PAR Common Stock prior to closing.
Material Changes and Transaction Structure
The Company has agreed to sell all assets, properties, and rights primarily related to its Bridg platform. The Buyer will assume certain liabilities associated with these assets. No other assets of Cardlytics are being acquired. The transaction includes a five-year non-competition and non-solicitation covenant for Cardlytics regarding the Purchased Assets.
Outlook, Risks, and Conditions
Closing Conditions: The transaction is subject to customary conditions, including the absence of governmental restraints and no material adverse effect on the Bridg platform or the Company's ability to close.
Termination Rights: The agreement may be terminated by the Buyer if closing conditions are not fulfilled by March 24, 2026, unless the failure is due to the Buyer's non-performance.
Risks and Uncertainties: Management cautions that the completion of the sale and receipt of consideration are forward-looking statements subject to risks, including the satisfaction of closing conditions and technical difficulties. The filing references risks detailed in the Company's Form 10-Q for the quarter ended September 30, 2025.
Investor Verification Checklist
- Verify the final closing date and whether the March 24, 2026 termination deadline is met.
- Confirm the final number of PAR Common Stock shares issued based on the 15-day VWAP at closing.
- Review the specific adjustments to the $27.5 million base price regarding new customer contracts and deferred revenue.
- Monitor the filing of the Purchase Agreement as an exhibit to the Company's Form 10-K for the year ended December 31, 2025.
- Assess the impact of the Bridg platform sale on Cardlytics' remaining business operations and future revenue streams.